The importance of hypertension of the pulmonary circulation in the natural history of mitral stenosis has been appreciated for many years. Many of the classic signs of this type of cardiac disease ...

Weak: only small or nonrandomized trials available; Unknown: not enough data to determine benefit. ERA: Endothelin receptor antagonist; PDE5: Phosphodiesterase type 5; PH: Pulmonary hypertension.

If you have pulmonary hypertension, it means you have high blood pressure in your pulmonary arteries, the blood vessels that carry blood from the right side of your heart through your lungs.

the team saw decreased cardiac pathology. Right ventricular hypertrophy, right ventricular systolic pressure, and vascular remodeling—all complications of pulmonary hypertension—were reduced ...

Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension (PPH). Recently, fenfluramine appetite suppressants became widely ...

Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for ...

Pulmonary Hypertension Right Heart Catheterization Service (Pulmonary Hypertension Program) Fellows gain procedural expertise in performing right heart catheterization, with and without vasodilator ...

The PAH Initiative is hosting a video event in May to provide information about exercise benefits for PAH patients.

"Pulmonary hypertension usually affects people aged 30 to 60. Its early signs and symptoms can mimic those of various other medical conditions, making early detection challenging," explains Dr Garde.

Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

The seventh edition of the International Meeting on Pulmonary Hypertension Clinical Treatment (IMPAHCT), organized by the pharmaceutical company Ferrer, gathered over 150 experts in pulmonology ...